Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Asia Heart Hospital is a prominent private, Grade 3A specialty hospital in China focused exclusively on cardiovascular health. Founded in 1999, it has grown into one of the nation's most active cardiac centers, specializing in complex heart surgeries, interventional cardiology, and pediatric cardiac care. The institution is known for its high volume of procedures, including coronary artery bypass grafting and percutaneous coronary interventions. Beyond clinical care, the hospital engages in significant clinical research and serves as a training center for cardiovascular specialists in the region. It was the first large-scale private heart hospital in China and maintains a reputation for high-quality patient outcomes and advanced medical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Asia Heart Hospital.